Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | CRHR1 | P34998 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17210749 | 0.80 | CA1 (0.59) | SMN1; SMN2CA12CA1CA2CA7 | |
| SCHEMBL27562205 | 0.77 | TUBB1 (0.38) | SMN1; SMN2CA2CA4MAPK1CRHR1 | |
| SCHEMBL24926176 | 0.77 | SMN1; SMN2 (0.50) | SMN1; SMN2CA12CA1CA2CA7 | |
| Propane SCHEMBL27582651 | 0.77 | SMN1; SMN2 (0.60) | SMN1; SMN2CA12CA1CA2CA7 | |
| SCHEMBL12707869 | 0.76 | TUBB1 (0.59) | — | |
| SCHEMBL13594743 | 0.76 | ADRA2A (0.46) | SMN1; SMN2MCHR1KDM4ELMNACYP3A4 | |
| SCHEMBL28000332 | 0.76 | SMN1; SMN2 (0.48) | SMN1; SMN2CA12CA1CA2CA7 | |
| SCHEMBL11749913 | 0.74 | SMN1; SMN2 (0.47) | SMN1; SMN2CA12CA1CA2CA7 | |
| SCHEMBL19612192 | 0.74 | SMN1; SMN2 (0.47) | SMN1; SMN2CA12CA1CA2CA7 | |
| SCHEMBL10661795 | 0.74 | SMN1; SMN2 (0.47) | SMN1; SMN2CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1146036-B1 | Tamiflu, Gallocarboxylic acid approach | HOFFMANN LA ROCHE (CH) | 2005-03-23 | — | — | EP | disclosed |
| US-6518048-B2 | Hydrogenation a isophthalic acid derivative | HOFFMANN-LA ROCHE INC. | 2003-02-11 | — | — | US | disclosed |
| US-20010036653-A1 | Stereo-specific synthesis of shimikic acid derivatives with improved efficiency | F. HOFFMANN-LA ROCHE AG (CH) | 2001-11-01 | — | — | US | disclosed |
| EP-1146036-A2 | Tamiflu, Gallocarboxylic acid approach | F. HOFFMANN-LA ROCHE AG (CH) | 2001-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010036653-A1 | Stereo-specific synthesis of shimikic acid derivatives with improved efficiency | DDC, ACE, NEU1 | SMN1; SMN2 1768/4885CA12 194/4885CA1 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.